The Company has developed novel, patentable, static antimicrobial formulas. These technologies are effective and durable while safely binding to target
surfaces providing residual antimicrobial efficacy. Recently, Clearstream has obtained a ground breaking EPA registration and these proprietary formulations give Clearstream a distinct advantage in the nearly 30-billion-dollar combined
antimicrobial and fungicide marketplace.